CHARACTERIZATION OF A NEW MODEL OF HUMAN PROSTATIC-CANCER - THE MULTICELLULAR TUMOR SPHEROID

被引:18
作者
DONALDSON, JT
TUCKER, JA
KEANE, TE
WALTHER, PJ
WEBB, KS
机构
[1] DUKE UNIV, MED CTR, SCH MED, DEPT SURG, DIV UROL, BOX 3062, DURHAM, NC 27710 USA
[2] DUKE UNIV, SCH MED, DEPT PATHOL, DURHAM, NC 27706 USA
[3] VET ADM MED CTR, MED RES SERV, DURHAM, NC 27705 USA
关键词
D O I
10.1002/ijc.2910460216
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multicellular tumor spheroids (MTS) provide a closer in vitro correlate to in vivo malignancy than do conventional monolayer cultures; while simulating many parameters of in vivo growth, MTS systems provide those perquisites (i. e., experimental control, economy, expediency) associated with in vitro evaluation of preclinical therapeutic strategies. For these reasons, we exploited the proclivity of the highly metastatic human prostatic carcinoma subline I‐LN‐PC3‐IA to spontaneously assume a spheroid morphology under routine culture conditions. I‐LN spheroids demonstrate salient features described in other spheroid systems and exhibit histologic characteristics of human prostate carcinoma. Cells encompassed in the I‐LN spheroid format demonstrated functional divergence from their monolayer counterparts with respect to immunoreactivity for prostatic acid phosphatase, positional dependence of prostate‐restricted p40 antigen expression, and chemotherapeutic drug response. This new in vitro‐in vivo transition model of human prostatic carcinoma should provide a valuable in vitro context to expediently evaluate in vivo correlates of oncolytic protocols on a malignancy that remains refractive to therapy. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:238 / 244
页数:7
相关论文
共 31 条
  • [1] BRADSHAW LJ, 1966, INTRO MOL BIOL TECHN, P142
  • [2] FORMATION AND GROWTH OF MULTICELLULAR SPHEROIDS OF HUMAN-ORIGIN
    CARLSSON, J
    NILSSON, K
    WESTERMARK, B
    PONTEN, J
    SUNDSTROM, C
    LARSSON, E
    BERGH, J
    PAHLMAN, S
    BUSCH, C
    COLLINS, VP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (05) : 523 - 533
  • [3] Choe B K, 1980, Prostate, V1, P383, DOI 10.1002/pros.2990010402
  • [4] COFFEY DS, 1983, CLIN ONCOL, V2, P479
  • [5] DISTRIBUTION AND ACTIVITY OF ANTINEOPLASTIC DRUGS IN A TUMOR-MODEL
    DURAND, RE
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (02): : 146 - 152
  • [6] CELL-CYCLE KINETICS IN AN INVITRO TUMOR MODEL
    DURAND, RE
    [J]. CELL AND TISSUE KINETICS, 1976, 9 (05): : 403 - 412
  • [7] DURAND RE, 1988, NATL CANCER I MONOGR, V6, P95
  • [8] ERLICHMAN C, 1985, J NATL CANCER I, V75, P499
  • [9] ERLICHMAN C, 1984, CANCER RES, V44, P5369
  • [10] GITTES RF, 1979, PROGR CLIN BIOL RES, V37, P31